Angiotensin II inhibits activity of human organic anion transporter 3 through activation of protein kinase Cα: Accelerating endocytosis of the transporter

2009/10/29 by Peng Duan, Shanshan Li, Guofeng You · 25 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Drug Transport and Resistance Mechanisms #Ion Transport and Channel Regulation #Renin-Angiotensin System Studies

paper · doi:10.1016/j.ejphar.2009.10.048

Cited by

• Protein Kinases and Cross-talk between Post-translational Modifications in the Regulation of Drug Transporters
• Distinct proteomic signatures of urinary extracellular vesicles link to albuminuria and treatment responses in diabetic kidney disease
• Potent inhibitors of human organic anion transporters 1 and 3 from clinical drug libraries: discovery and molecular characterization. [europepmc]
• Renal organic anion transporters (SLC22 family): expression, regulation, roles in toxicity, and impact on injury and disease. [europepmc]
• Regulation of renal organic anion transporter 3 (SLC22A8) expression and function by the integrity of lipid raft domains and their associated cytoskeleton. [europepmc]
• Antidiabetic and renoprotective effects of Cladophora glomerata Kützing extract in experimental type 2 diabetic rats: a potential nutraceutical product for diabetic nephropathy. [europepmc]
• Downregulation of Organic Anion Transporting Polypeptide (OATP) 1B1 Transport Function by Lysosomotropic Drug Chloroquine: Implication in OATP-Mediated Drug-Drug Interactions. [europepmc]
• Posttranslational Regulation of Organic Anion Transporters by Ubiquitination: Known and Novel. [europepmc]
• Pretreatment With Rifampicin and Tyrosine Kinase Inhibitor Dasatinib Potentiates the Inhibitory Effects Toward OATP1B1- and OATP1B3-Mediated Transport. [europepmc]
• Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression. [europepmc]
• Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner. [europepmc]
• AG490, a JAK2-specific inhibitor, downregulates the expression and activity of organic anion transporter-3. [europepmc]
• The mechanistic links between insulin and human organic anion transporter 4. [europepmc]
• Activation of Protein Kinase A Stimulates SUMOylation, Expression, and Transport Activity of Organic Anion Transporter 3. [europepmc]
• The SUMO-Specific Protease Senp2 Regulates SUMOylation, Expression and Function of Human Organic Anion Transporter 3. [europepmc]
• Insulin-like growth factor 1 modulates the phosphorylation, expression, and activity of organic anion transporter 3 through protein kinase A signaling pathway. [europepmc]
• Regulation of organic anion transporters: Role in physiology, pathophysiology, and drug elimination. [europepmc]
• Ubiquitin-specific peptidase 8 regulates the trafficking and stability of the human organic anion transporter 1. [europepmc]
• Plasma indoxyl sulfate levels predict cardiovascular events in patients with mild chronic heart failure. [europepmc]
• Post-translational regulation of the major drug transporters in the families of organic anion transporters and organic anion-transporting polypeptides. [europepmc]
• Peptide Hormone Insulin Regulates Function, Expression, and SUMOylation of Organic Anion Transporter 3. [europepmc]
• Is It Time to Use Modeling of Cellular Transporter Homeostasis to Inform Drug-Drug Interaction Studies: Theoretical Considerations. [europepmc]
• Inhibition of proteasome, but not lysosome, upregulates organic anion transporter 3 in vitro and in vivo. [europepmc]
• Topotecan and Ginkgolic Acid Inhibit the Expression and Transport Activity of Human Organic Anion Transporter 3 by Suppressing SUMOylation of the Transporter. [europepmc]
• Recent Advances on the Regulations of Organic Anion Transporters. [europepmc]